The/DT
candidate/NN
oncoprotein/NN
Bcl-3/NN
is/VBZ
an/DT
antagonist/NN
of/IN
p50/NF-kappa/NN
B-mediated/JJ
inhibition/NN
./.

The/DT
candidate/NN
oncogene/NN
bcl-3/NN
was/VBD
discovered/VBN
as/IN
a/DT
translocation/NN
into/IN
the/DT
immunoglobulin/NN
alpha-locus/NN
in/IN
some/DT
cases/NNS
of/IN
B-cell/NN
chronic/JJ
lymphocytic/JJ
leukaemias/NNS
./.
=====
The/DT
protein/NN
Bcl-3/NN
contains/VBZ
seven/CD
so-called/JJ
ankyrin/NN
repeats/NNS
./.
=====
Similar/JJ
repeat/NN
motifs/NNS
are/VBP
found/VBN
in/IN
a/DT
number/NN
of/IN
diverse/JJ
regulatory/JJ
proteins/NNS
but/CC
the/DT
motifs/NNS
of/IN
Bcl-3/NN
are/VBP
most/RBS
closely/RB
related/JJ
to/TO
those/DT
found/VBN
in/IN
I/NN
kappa/NN
B/NN
proteins/NNS
in/IN
which/WDT
the/DT
ankyrin/NN
repeat/NN
domain/NN
is/VBZ
thought/VBN
to/TO
be/VB
directly/RB
involved/VBN
in/IN
inhibition/NN
of/IN
NF-kappa/NN
B/NN
activity/NN
./.
=====
No/DT
biological/JJ
function/NN
has/VBZ
yet/RB
been/VBN
described/VBN
for/IN
Bcl-3/NN
,/,
but/CC
it/PRP
was/VBD
noted/VBN
recently/RB
that/IN
Bcl-3/NN
interferes/VBZ
with/IN
DNA-binding/NN
of/IN
the/DT
p50/NN
subunit/NN
of/IN
NF-kappa/NN
B/NN
in/FW
vitro/FW
./.
=====
Here/RB
we/PRP
demonstrate/VBP
that/IN
Bcl-3/NN
can/MD
aid/VB
kappa/NN
B/NN
site-dependent/JJ
transcription/NN
in/FW
vivo/FW
by/IN
counteracting/VBG
the/DT
inhibitory/JJ
effects/NNS
of/IN
p50/NF-kappa/NN
B/NN
homodimers/NNS
./.
=====
Bcl-3/NN
may/MD
therefore/RB
aid/VB
activation/NN
of/IN
select/JJ
NF-kappa/NN
B-regulated/JJ
genes/NNS
,/,
including/VBG
those/DT
of/IN
the/DT
human/JJ
immunodeficiency/NN
virus/NN
./.